Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Daily Stock Opinions and Ratings
Stockchase Opinions

Norman LevineGenentechDNAHOLDJul 21, 2008

Once a takeover bid comes in, it no longer trades on fundamentals. If you already own, keep the stock and wait to see what happens. You could take a bit of profit here.
Norman LevineNorman Levine
Unknown
Unlock Rating
$93.88

Stock price when the opinion was issued

$7.89

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Genentech(DNA)

Jun 21, 2007
The model price is $48.70, a negative 35% differential. Would choose Amgen (AMGN-Q), which he owns.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$75.97

Stock price when the opinion was issued

$7.89

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Genentech(DNA)

Jun 07, 2007
One of the largest bio-tech firms in the world. He thinks there is not enough control, in knowing how research is going to be able to proceed. (phase 1 through phase 6). Instead he uses PBE-A which is a portfolio. Less exciting but more rewarding long term.
Photo of Charles LannonCharles Lannon
No
Unlock Rating
$74.90

Stock price when the opinion was issued

$7.89

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
BUY

Genentech(DNA)

Jul 13, 2005
The biotech sector is one of the first growth oriented groups that turned up and has been relatively strong all year. Likes this one because it has a diversified revenue line. Growing cash flow.
Photo of David BurrowsDavid Burrows
Owned
Unlock Rating
$86.65

Stock price when the opinion was issued

$7.89

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Genentech(DNA)

May 24, 2005
Model price is $25.24. Very expensive.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$78.60

Stock price when the opinion was issued

$7.89

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Genentech(DNA)

Aug 29, 2001
Growing revenue profits annually 25%. Good products. Good value at this price.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$47.25

Stock price when the opinion was issued

$7.89

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica